CORV News and Press, Correvio Pharma Corp. From 04/30/19

Play Video Day one of the Bloom Burton & Co. Healthcare Investor Conference (BBHIC) has officially wrapped up and the start of the annual show proved to be another roaring success.  Now in its eighth ye...

The Canadian pharmaceutical industry has been on a steady incline over the last several years thanks to new developments in medicine and exciting opportunities presenting themselves, according to a 2018 report from Research and Markets . Separately, analysis from PwC Canada indicates the ...

HENDERSON, NV / ACCESSWIRE / April 9, 2019 / As per the report, "The Cannabis Energy Report: Current and Evolving State of Cannabis Energy Consumption" published by New Frontier Data, cannabis cultivation (legal and illicit) in the US consumed an estimated 4.1 million MWh of electricity in 2...

NASDAQ: CORV   TSX: CORV Seven Data Abstracts Selected for Poster Presentations   VANCOUVER , April 3, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced...

Correvio to present at the H.C. Wainwright Global Life Sciences Conference Canada NewsWire VANCOUVER, April 2, 2019 NASDAQ: CORV  TSX: CORV VANCOUVER , April 2, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company ...

The following slide deck was published by Correvio Pharma Corp. in conjunction with their 2018 Q4 earnings Read more ...

Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting Canada NewsWire VANCOUVER, March 20, 2019 Data Will Also Be Presented at the Upcoming 23 rd Israeli Congress for Emergency Medicine   NASDAQ: COR...

Correvio Announces at the Market Offering Canada NewsWire VANCOUVER, March 14, 2019 NASDAQ: CORV TSX: CORV VANCOUVER , March 14, 2019 /CNW/ - Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), ("Correvio" or the "Company"), a specialty pharmaceutical company focused on ...

Correvio Pharma Corp. (CORV) Q4 2018 Results Earnings Conference Call March 13, 2019 08:00 AM ET Company Participants Justin Renz - Chief Financial Officer Dr. Bill Hunter - President and CEO Dr. Mark Corrigan - Incoming CEO David Dean - Chief Business Development Officer ...

Correvio Pharma (NASDAQ: CORV ): Q4 GAAP EPS of -$0.18 beats by $0.03 . More news on: Correvio Pharma Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...